CN101456869B - 萘夫西林钠的合成方法 - Google Patents
萘夫西林钠的合成方法 Download PDFInfo
- Publication number
- CN101456869B CN101456869B CN2008100802929A CN200810080292A CN101456869B CN 101456869 B CN101456869 B CN 101456869B CN 2008100802929 A CN2008100802929 A CN 2008100802929A CN 200810080292 A CN200810080292 A CN 200810080292A CN 101456869 B CN101456869 B CN 101456869B
- Authority
- CN
- China
- Prior art keywords
- solution
- phase
- nafcillin sodium
- reaction
- organic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- OCXSDHJRMYFTMA-KMFBOIRUSA-M nafcillin sodium monohydrate Chemical compound O.[Na+].C1=CC=CC2=C(C(=O)N[C@@H]3C(N4[C@H](C(C)(C)S[C@@H]43)C([O-])=O)=O)C(OCC)=CC=C21 OCXSDHJRMYFTMA-KMFBOIRUSA-M 0.000 title claims abstract description 39
- 229960001775 nafcillin sodium Drugs 0.000 title claims abstract description 37
- 238000010189 synthetic method Methods 0.000 title claims description 17
- 238000006243 chemical reaction Methods 0.000 claims abstract description 35
- NGHVIOIJCVXTGV-ALEPSDHESA-N 6-aminopenicillanic acid Chemical compound [O-]C(=O)[C@H]1C(C)(C)S[C@@H]2[C@H]([NH3+])C(=O)N21 NGHVIOIJCVXTGV-ALEPSDHESA-N 0.000 claims abstract description 21
- NGHVIOIJCVXTGV-UHFFFAOYSA-N 6beta-amino-penicillanic acid Natural products OC(=O)C1C(C)(C)SC2C(N)C(=O)N21 NGHVIOIJCVXTGV-UHFFFAOYSA-N 0.000 claims abstract description 21
- 150000001263 acyl chlorides Chemical class 0.000 claims abstract description 21
- 239000012074 organic phase Substances 0.000 claims abstract description 21
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000012043 crude product Substances 0.000 claims abstract description 18
- 239000003960 organic solvent Substances 0.000 claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000003054 catalyst Substances 0.000 claims abstract description 9
- 238000005660 chlorination reaction Methods 0.000 claims abstract description 5
- 238000010992 reflux Methods 0.000 claims abstract description 5
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 36
- 239000000243 solution Substances 0.000 claims description 35
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 16
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 14
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 8
- 239000003513 alkali Substances 0.000 claims description 8
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 8
- 239000008346 aqueous phase Substances 0.000 claims description 7
- 238000005352 clarification Methods 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 238000010792 warming Methods 0.000 claims description 7
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 238000009413 insulation Methods 0.000 claims description 5
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical compound CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 claims description 4
- FJBFPHVGVWTDIP-UHFFFAOYSA-N dibromomethane Chemical compound BrCBr FJBFPHVGVWTDIP-UHFFFAOYSA-N 0.000 claims description 4
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 claims description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- 235000017550 sodium carbonate Nutrition 0.000 claims description 3
- 150000003462 sulfoxides Chemical class 0.000 claims description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 239000001117 sulphuric acid Substances 0.000 claims description 2
- 235000011149 sulphuric acid Nutrition 0.000 claims description 2
- 238000006482 condensation reaction Methods 0.000 abstract description 4
- 238000000034 method Methods 0.000 abstract description 4
- 239000000047 product Substances 0.000 abstract description 4
- 230000006378 damage Effects 0.000 abstract description 3
- 239000012071 phase Substances 0.000 abstract 4
- 125000002252 acyl group Chemical group 0.000 abstract 2
- 230000002194 synthesizing effect Effects 0.000 abstract 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 abstract 2
- MYFBSSDLYGWAHH-UHFFFAOYSA-N 2-ethoxynaphthalene-1-carboxylic acid Chemical compound C1=CC=CC2=C(C(O)=O)C(OCC)=CC=C21 MYFBSSDLYGWAHH-UHFFFAOYSA-N 0.000 abstract 1
- 238000003912 environmental pollution Methods 0.000 abstract 1
- 238000001704 evaporation Methods 0.000 abstract 1
- 150000007530 organic bases Chemical class 0.000 abstract 1
- 229960000515 nafcillin Drugs 0.000 description 5
- GPXLMGHLHQJAGZ-JTDSTZFVSA-N nafcillin Chemical compound C1=CC=CC2=C(C(=O)N[C@@H]3C(N4[C@H](C(C)(C)S[C@@H]43)C(O)=O)=O)C(OCC)=CC=C21 GPXLMGHLHQJAGZ-JTDSTZFVSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 4
- 229960001701 chloroform Drugs 0.000 description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 229930182555 Penicillin Natural products 0.000 description 3
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 3
- 229940049954 penicillin Drugs 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000007086 side reaction Methods 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010071699 Infectious pleural effusion Diseases 0.000 description 1
- 206010024652 Liver abscess Diseases 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 206010014665 endocarditis Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100802929A CN101456869B (zh) | 2008-12-30 | 2008-12-30 | 萘夫西林钠的合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100802929A CN101456869B (zh) | 2008-12-30 | 2008-12-30 | 萘夫西林钠的合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101456869A CN101456869A (zh) | 2009-06-17 |
CN101456869B true CN101456869B (zh) | 2011-01-26 |
Family
ID=40768019
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008100802929A Active CN101456869B (zh) | 2008-12-30 | 2008-12-30 | 萘夫西林钠的合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101456869B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102249902B (zh) * | 2011-05-26 | 2013-11-27 | 朗致集团博康药业有限公司 | 1-氯甲酰基-2-乙氧基萘结晶的制备方法 |
CN102250119B (zh) * | 2011-05-26 | 2013-11-27 | 朗致集团博康药业有限公司 | 一种由萘夫西林酸制备萘夫西林钠一水合物的方法 |
CN104356143B (zh) * | 2014-10-27 | 2017-08-29 | 桂林南药股份有限公司 | 一种萘夫西林酸的制备方法 |
CN106800565A (zh) * | 2016-12-08 | 2017-06-06 | 桂林南药股份有限公司 | 一种萘夫西林钠晶型及其制备方法 |
-
2008
- 2008-12-30 CN CN2008100802929A patent/CN101456869B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN101456869A (zh) | 2009-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101456869B (zh) | 萘夫西林钠的合成方法 | |
CN101570543B (zh) | 一种美洛西林钠溶媒结晶制备方法 | |
CN105085544A (zh) | 一种他唑巴坦二苯甲酯的合成方法 | |
CN101781315A (zh) | 一种萘夫西林钠一水合物的合成方法 | |
CN102180888B (zh) | 一种7-氨基-3-无-3-头孢烯-4-羧酸(7-anca)的制备方法 | |
CN104326990A (zh) | 一种胞嘧啶氟化合成5-氟胞嘧啶的方法 | |
CN101362752B (zh) | 一种拉米夫定中间体的合成方法 | |
CN102140103A (zh) | 以青霉素g/k为原料制备7-氨基-3-氢头孢烷酸的方法 | |
CN111018811A (zh) | 一种制备α-氯代-α-乙酰基-γ-丁内酯的方法 | |
CN101560219A (zh) | 1β甲基碳青霉烯类抗生素中间体的合成方法 | |
CN102267992B (zh) | 一种截短侧耳素类抗生素的制备方法 | |
CN102344459B (zh) | 一种头孢中间体gcle的制备方法 | |
CN105348212B (zh) | 利奈唑胺的制备方法 | |
CN102134249B (zh) | 一种手性5-保护-2-硫杂-5-氮杂双环[2.2.1]庚-3-酮的制备方法 | |
CN102936614B (zh) | 7-α-甲氧基-3-去乙酰基头孢噻吩苄星盐的合成方法 | |
CN105254650A (zh) | 抗菌药物头孢西丁酸的合成方法 | |
CN101857600B (zh) | 一种7-苯乙酰氨基-3-甲基头孢烷酸的制备方法 | |
CN102250118B (zh) | 以1-氯甲酰基-2-乙氧基萘固体合成萘夫西林钠的方法 | |
CN105503881B (zh) | 一种吡咯并吡嗪的制备方法 | |
CN104447511A (zh) | 一种n-叔丁氧羰基-3-哌啶酮的合成方法 | |
CN1176081C (zh) | 制备喜勃酮用的中间体及其制备方法 | |
CN101456867B (zh) | 呋苄西林酸的合成方法 | |
CN105037348B (zh) | 一种瑞他莫林合成方法 | |
CN102675175A (zh) | 一种西司他丁的分离纯化方法 | |
CN1966712A (zh) | 修饰纤维素酶催化提取薯蓣皂素的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: LONGCH GROUP GUARDDIAN PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: SHANXI BOKANG PHARMACEUTICAL CO., LTD. OF NCPC Effective date: 20140409 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20140409 Address after: 030021 No. 1, Chemical Road, Jinyuan District, Shanxi, Taiyuan Patentee after: North Pharmaceutical Group Shanxi Bokang Pharmaceutical Co.,Ltd. Address before: 030021 No. 1, Chemical Road, Jinyuan District, Shanxi, Taiyuan Patentee before: North Pharmaceutical Group Shanxi Bokang Pharmaceutical Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191119 Address after: 100176 No.1, dize North Street, Beijing Economic and Technological Development Zone Patentee after: Beijing shengkejia Electronic Co., Ltd Address before: 030021 No. 1, Chemical Road, Jinyuan District, Shanxi, Taiyuan Patentee before: Langzhi Group Bokang Pharmaceutical Co., Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20201120 Address after: No.8, Industrial Avenue, furniture base, Longling Industrial Park, Nankang District, Ganzhou City, Jiangxi Province Patentee after: LONCH GROUP JIANGXI PHARMACEUTICAL Co.,Ltd. Address before: 100176 No.1, dize North Street, Beijing Economic and Technological Development Zone Patentee before: Beijing shengkejia Electronic Co.,Ltd. |
|
TR01 | Transfer of patent right |